Skip to content

Effect of Exclusive Enteral Nutrition on Disease Process, Nutritional Status and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease

Effect of Exclusive Enteral Nutrition on Disease Process, Nutritional Status and Intestinal Microbiota for Chinese Children With Crohn's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03755583
Enrollment
31
Registered
2018-11-28
Start date
2017-02-01
Completion date
2019-12-31
Last updated
2020-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease, Enteral Nutrition, Gastrointestinal Microbiome

Keywords

Exclusive enteral nutrition

Brief summary

Inflammatory bowel diseases (IBD) are chronic inflammatory diseases. It is believed that the inflammation results from sustained abnormal immune response towards altered or pathogenic microbiota in genetically susceptible hosts. Malnutrition is common in IBD, especially in pediatric Crohn's disease(CD). Exclusive enteral nutrion(EEN) has been shown to improve nutritional status and inflammatory markers in pediatric CD. But there is limited data about the effect of EEN on Chinese children with CD. In this study, investigators focused on disease process,nutritional status and gut microbiome of Chinese children with newly-diagnosed CD after EEN treatment.

Interventions

DIETARY_SUPPLEMENTExclusive Enteral Nutrition

a complete liquid diet of formula for 8 weeks were adminstered in Crohn's Diseas patients ,Nutritional intake was based on the child's estimated energy requirements, no regular table food during 8 weeks treament.

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Pediatric CD patients who were newly diagnosed and being treated with EEN at the Children's Hospital of Fudan University

Exclusion criteria

* (1) patients who were administered corticosteroids, immunosuppressive drugs, or biological agents prior to the study; (2) patients who could not finish the daily prescribed volume of formula for any reason; (3) patients who could not attend consecutive follow-up sessions; (4) patients who had received antibiotics or probiotics within 1.5 months prior to the study; and (5) patients who had been given corticosteroids, immunosuppressive drugs, biological agents, antibiotics, or probiotics during the EEN process.

Design outcomes

Primary

MeasureTime frameDescription
5-item gut microbiota measure0, 2, 6, 8, 12 weeks post-EENthe change of gut microbiota during EEN and after the end of EEN
2-item Simple Endoscopic Score for CD (SES-CD)0, 8, weeks post-EENAccording to the SES-CD, at the end of EEN, the patients whose SES-CD scores were ≤4 were classified into the remission group (CD-RE), other patients whose SES-CD scores were \>4 were classified into the non-remission group (CD-NRE)

Secondary

MeasureTime frameDescription
2-item 25-hydroxyvitamin D3 measure (25-OH VITD3)0,8 weeks post-EENthe level of 25-OH VITD3 in 8 weeks post-EEN is higher than 0 week represents a better outcome
5-item weight measure0, 2, 6, 8, 12 weeks post-EEN
2-item Calcium, vitamin0, 8 weeks post-EEN
5-item Fecal Calprotectin0, 2, 6, 8, 12 weeks post-EEN
2-item Insulin-like growth factor-10, 8 weeks post-EEN
5-item height measure0, 2, 6, 8, 12 weeks post-EEN
5-item weighted Paediatric Crohn's disease activity index measure(wPCDAI)0, 2, 6, 8, 12 weeks post-EENwPCDAI scoret included 8 items (Abdominal pain, Patient functioning, Stools, ESR, Albumin, Weight, Perirectal disease, Extraintestinal manifestations ).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026